Company / Shareholders' Equity
Tonix Pharmaceuticals Holding Corp. Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$139.6M
FY2025
5-year range
$105.5M / $207.2M
FY2023-FY2025
Trend
+32.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $207M to $140M over the past 2 years.
Based on SEC 10-K filings.
$140M in FY2025.
Declined from $207M to $140M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity increased 32.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $139.6M | +32.3% |
| FY2024 | $105.5M | -49.1% |
| FY2023 | $207.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026